Diagnostic Accuracy of Five Different Fecal Markers for the Detection of Precancerous and Cancerous Lesions of the Colorectum
- PMID: 27413251
- PMCID: PMC4927976
- DOI: 10.1155/2016/2492081
Diagnostic Accuracy of Five Different Fecal Markers for the Detection of Precancerous and Cancerous Lesions of the Colorectum
Abstract
Background. Colorectal cancer (CRC) is the second deadliest malignancy worldwide. This study aimed to compare the diagnostic accuracy of different fecal markers in the detection of colorectal adenomas and cancer. Methods. Stool samples of patients referred to colonoscopy were collected for the analysis of tumor M2 pyruvate kinase (M2PK), human hemoglobin (Hb), hemoglobin/haptoglobin (Hb/Hp) complex, fecal calprotectin (FC), and matrix metalloproteinase-9 (MMP-9). Results. Sensitivity and specificity of M2PK for adenomas sized > 1 cm were 60% and 67.5% and for CRC were 94.7% and 67.5%. Sensitivity and specificity of iFOBT for adenomas sized ≥ 1 cm were 80% and 72.5% and for CRC were 94.7% and 72.5%. Sensitivity and specificity of Hb/Hp complex for adenomas sized ≥ 1 cm were 80% and 52.9% and for CRC were 100% and 52.9%. Sensitivity of FC and MMP-9 for CRC was 77.8% and 72.2%. Combined use of M2PK, iFOBT, and FC resulted in a sensitivity and specificity of 95% and 47.5% for the detection of adenomas sized ≥ 1 cm. Discussion. In CRC, sensitivity of M2PK, iFOBT, and Hb/Hp complex proved to be high. Combined use of M2PK, iFOBT, and FC may be valuable in the detection of large adenomas.
Similar articles
-
Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers.Clin Gastroenterol Hepatol. 2008 Oct;6(10):1122-8. doi: 10.1016/j.cgh.2008.04.021. Clin Gastroenterol Hepatol. 2008. PMID: 18928937
-
KRAS mutations and M2PK upregulation in stool samples from individuals with positive fecal occult blood tests screened for colorectal cancer.Tumori. 2014 Mar-Apr;100(2):122-7. doi: 10.1177/030089161410000202. Tumori. 2014. PMID: 24852854
-
Evaluation of Fecal M2PK as a Diagnostic Marker in Colorectal Cancer.J Gastrointest Cancer. 2019 Sep;50(3):442-450. doi: 10.1007/s12029-018-0088-1. J Gastrointest Cancer. 2019. PMID: 29626277
-
Stool test for colorectal cancer screening--it's time to move!Clin Lab. 2008;54(11-12):473-84. Clin Lab. 2008. PMID: 19216253 Review.
-
[Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].Gastroenterol Hepatol. 2009 Oct;32(8):565-76. doi: 10.1016/j.gastrohep.2009.01.179. Epub 2009 Jul 3. Gastroenterol Hepatol. 2009. PMID: 19577340 Review. Spanish.
Cited by
-
Diagnostic accuracy of fecal calprotectin for screening patients with colorectal cancer: A meta-analysis.Turk J Gastroenterol. 2018 Jul;29(4):397-405. doi: 10.5152/tjg.2018.17606. Turk J Gastroenterol. 2018. PMID: 30249553 Free PMC article.
-
The Value of Multi-targeted Fecal DNA Methylation Detection for Colorectal Cancer Screening in a Chinese Population.J Cancer. 2021 Jan 15;12(6):1644-1650. doi: 10.7150/jca.47214. eCollection 2021. J Cancer. 2021. PMID: 33613751 Free PMC article.
-
Elevated Faecal Calprotectin in Patients with a Normal Colonoscopy: Does It Matter in Clinical Practice? A Retrospective Observational Study.Inflamm Intest Dis. 2021 May;6(2):101-108. doi: 10.1159/000513473. Epub 2021 Feb 17. Inflamm Intest Dis. 2021. PMID: 34124181 Free PMC article.
-
Clinical utility of fecal calprotectin: potential applications beyond inflammatory bowel disease for the primary care physician.Ann Gastroenterol. 2019 Sep-Oct;32(5):425-430. doi: 10.20524/aog.2019.0394. Epub 2019 Jun 20. Ann Gastroenterol. 2019. PMID: 31474787 Free PMC article. Review.
-
Aberrant circulating tumor DNA methylation and exosomal microRNA biomarkers for early detection of colorectal cancer.Mol Biol Rep. 2023 Mar;50(3):2743-2750. doi: 10.1007/s11033-022-08194-3. Epub 2022 Dec 30. Mol Biol Rep. 2023. PMID: 36583782 Review.
References
-
- The Hungarian Central Statistical Office. Demographic Yearbook, 1963–2012. Budapest, Hungry: KSH; 2013.
-
- Vasilyev S., Smirnova E., Popov D., et al. A new-generation fecal immunochemical test (FIT) is superior to quaiac-based test in detecting colorectal neoplasia among colonoscopy referral patients. Anticancer Research. 2015;35(5):2873–2880. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous